Abstract 373: Impact of anti-angiogenic treatments on exhausted PD-1+ T lymphocytes in colorectal cancer.

作者
Magali Terme,Thibault Voron,Elie Marcheteau,Orianne Colussi,Simon Pernot,Éric Tartour,Julien Taı̈eb
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:73 (8_Supplement): 373-373
标识
DOI:10.1158/1538-7445.am2013-373
摘要

Abstract Background: The concept of cancer immunosurveillance suggests that the immune system can recognize and destroy tumor cells. However, tumors can develop immunosuppressive mechanisms to escape the immune system. Among the immunosuppressive mechanisms, T lymphocytes can express inhibitory molecules such as Program Death-1 (PD-1) protein which impair their activation. PD-1 activation by its ligands PD-L1 and PD-L2 blocks T cell proliferation, cytolytic activity, cytokine production, and decreases survival. Multi-target anti-angiogenic tyrosine kinase inhibitors (TKI) that are routinely used as first- or second-line treatment of cancer patients, have been shown to modulate immunosuppressive mechanisms especially regulatory T cells. However, the role of specific VEGF/VEGFR blockade on PD-1 expression by T lymphocytes has not been studied. Materiel and methods: PD-1 expression on T lymphocytes has been analyzed by flow cytometry in a mouse model of colorectal cancer (CT26) treated by anti-angiogenic molecules targeting the VEGF-A/VEGFR axis and in the peripheral blood of metastatic colorectal cancer patients. Results: Tumor-infiltrating CD4+ and CD8+ T lymphocytes express high levels of PD-1 in the CT26 tumor model. Sunitinib that directly targets VEGFR, PDGFR, c-kit, decreases PD-1 expression on CD4+ and CD8+ T lymphocytes infiltrating the tumors. In the same manner, anti-VEGF-A antibody (the mouse orthologue of bevacizumab) restrains PD-1 expression on tumor-infiltrating T lymphocytes. Interestingly, anti-angiogenic treatments decrease the percentage of lymphocytes expressing not only PD-1 but also Tim-3 suggesting that the most exhausted T cells are targeted by anti-angiogenic treatments. Administration of masitinib, a tyrosine kinase inhibitor acting on KIT, PDGFR and FAK but not on the VEGF/VEGF-R pathway, was not able to modulate PD-1 expression on T cells. Finally, anti-VEGF-A treatment (bevacizumab) associated with chemotherapy decreases the proportion of PD-1+ CD4+ T cells in the peripheral blood of metastatic colorectal cancer patients. Conclusions: These results show that anti-angiogenic treatments targeting VEGFA/VEGFR decrease PD-1-expressing T lymphocytes in colorectal cancer. These results suggest that VEGF-A could be involved in PD-1 expression and maybe in the induction of T lymphocyte exhaustion in colorectal cancer. This point is currently under investigation. We and others have shown that anti-angiogenic molecules could modulate other immunosuppressive populations such as regulatory T cells and myeloid suppressive cells, anti-angiogenic molecules might be efficiently associated with immunotherapeutic strategies in colorectal cancer. Citation Format: Magali Terme, Thibault Voron, Elie Marcheteau, Orianne Colussi, Simon Pernot, Eric Tartour, Julien Taieb. Impact of anti-angiogenic treatments on exhausted PD-1+ T lymphocytes in colorectal cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 373. doi:10.1158/1538-7445.AM2013-373

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
那年夏天完成签到,获得积分10
刚刚
刚刚
CodeCraft的应助被xiaomu采纳,获得10
1秒前
酷波er的应助被老橡树采纳,获得20
1秒前
LLL发布了新的文献求助10
1秒前
2秒前
TiAmo完成签到 ,获得积分10
4秒前
4秒前
4秒前
yy发布了新的文献求助10
5秒前
5秒前
cailiao完成签到,获得积分10
5秒前
StarletZhou完成签到,获得积分10
6秒前
怪奇物语完成签到,获得积分10
7秒前
7秒前
howdream发布了新的文献求助10
7秒前
小象完成签到,获得积分10
7秒前
7秒前
皮卡皮卡丘完成签到,获得积分10
8秒前
乐乐的应助被环游世界采纳,获得10
8秒前
dinghongmei发布了新的文献求助10
9秒前
tianxiao发布了新的文献求助10
9秒前
哈哈完成签到,获得积分10
9秒前
1111完成签到,获得积分10
9秒前
贪玩翅膀发布了新的文献求助80
10秒前
molihuakai的应助被陈明采纳,获得10
10秒前
ly完成签到,获得积分10
10秒前
凉雨街发布了新的文献求助10
10秒前
怪奇物语发布了新的文献求助10
10秒前
super chan发布了新的文献求助10
11秒前
方源的应助被cnkly采纳,获得30
12秒前
12秒前
小蘑菇的应助被yy采纳,获得10
12秒前
DiNg完成签到,获得积分10
12秒前
倩Q完成签到,获得积分10
12秒前
12秒前
13秒前
LLL完成签到,获得积分10
13秒前
吃饭饭完成签到,获得积分10
13秒前
哈哈发布了新的文献求助30
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153492
求助须知:如何正确求助?哪些是违规求助? 9550166
关于积分的说明 21696892
捐赠科研通 7742051
什么是DOI,文献DOI怎么找? 3425502
关于科研通互助平台的介绍 2550620
邀请新用户注册赠送积分活动 2469156